We are live on ! Find out more
BRC

BHF RG Capital Portfolio holdings

AUM $150M
1-Year Est. Return 18.4%
This Fund
S&P 500
This Quarter Est. Return
+9.57%
1 Year Est. Return
+18.4%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$133M
AUM Growth
+$14.4M
Cap. Flow
+$3.22M
Cap. Flow %
2.43%
Top 10 Hldgs %
78.29%
Holding
36
New
4
Increased
20
Reduced
12
Closed
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VUG icon
26
Vanguard Morningstar Growth ETF
VUG
$230B
$578K 0.44%
13,506
+90
+0.7% +$3.59K
IJR icon
27
iShares Core S&P Small-Cap ETF
IJR
$112B
$504K 0.38%
5,499
-48
-0.9% -$3.94K
FTA icon
28
First Trust Large Cap Value AlphaDEX Fund
FTA
$1.4B
$494K 0.37%
8,996
+50
+0.6% +$2.58K
VGLT icon
29
Vanguard Long-Term Treasury ETF
VGLT
$10.1B
$489K 0.37%
5,108
+82
+2% +$7.94K
AAPL icon
30
Apple
AAPL
$4.58T
$437K 0.33%
3,302
+5
+0.2% +$601
PRF icon
31
Invesco FTSE RAFI US 1000 ETF
PRF
$9.98B
$433K 0.33%
16,330
-1,285
-7% -$32K
VHT icon
32
Vanguard Health Care ETF
VHT
$18.4B
$275K 0.21%
1,232
-226
-16% -$48.3K
BBC icon
33
Virtus Biotech Clinical Trials ETF
BBC
$49.8M
$223K 0.17%
+4,692
New +$211K
PFFA icon
34
Virtus InfraCap US Preferred Stock ETF
PFFA
$2.48B
$221K 0.17%
+10,026
New +$208K
FXH icon
35
First Trust Health Care AlphaDEX Fund
FXH
$1.06B
$217K 0.16%
+2,007
New +$204K
NEE icon
36
NextEra Energy
NEE
$179B
$209K 0.16%
+2,703
New +$202K

Similar funds

BHF RG Capital's Q4 2020 Portfolio in Review

As of Q4 2020, BHF RG Capital held 36 positions worth $133M, up 12% from $118M the previous quarter. Its ten largest holdings account for 78% of the portfolio.

BHF RG Capital's Q4 2020 filing shows 4 new, 20 increased and 12 reduced positions. Its largest new stake was Virtus Biotech Clinical Trials ETF: 4,692 shares worth $223K. The largest sale was Invesco QQQ Trust, an estimated $111K.

By sector, the portfolio is most concentrated in Technology at 0.33% of assets, up from 0.32% a quarter earlier, followed by Utilities.

  • BHF RG Capital's largest Q4 2020 buy was Virtus Biotech Clinical Trials ETF: 4,692 shares worth $223K.
  • BHF RG Capital added most to Vanguard Intermediate-Term Bond ETF in Q4 2020, an estimated $928K increase.
  • BHF RG Capital's biggest Q4 2020 reduction was Invesco QQQ Trust, cutting an estimated $111K.
  • BHF RG Capital's ten largest holdings make up 78% of its $133M portfolio in Q4 2020.
  • BHF RG Capital opened 4 new positions and closed 0 in Q4 2020.
  • BHF RG Capital's portfolio value rose 12% quarter-over-quarter to $133M.

Based on BHF RG Capital's 13F filing for Q4 2020, filed 27 Jan 2021.